Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Rhabdomyosarcoma × trofosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma 1 Rhabdomyosarcoma 1

Interventions

Radiotherapy 9 Vincristine 8 Dactinomycin 7 Cyclophosphamide 7 Ifosfamide 6 Radiation 5 Doxorubicin 5 Irinotecan 4 Filgrastim 4 Etoposide 4 sargramostim 2 Vinorelbine 2 Granulocyte Colony-Stimulating Factor 2 trofosfamide 1 trioctyl phosphine oxide 1 temsirolimus 1 pegfilgrastim 1 etoposide phosphate 1 Topotecan 1 Surgical Procedures, Operative 1 Spinal Puncture 1 Specimen Handling 1 Sirolimus 1 Sentinel Lymph Node Biopsy 1 Magnetic Resonance Spectroscopy 1 Idarubicin 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Epirubicin 1 Diathermy 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00876031 2022-11-08

CWS-2007-HR

University Hospital Tuebingen

Phase 3 Completed

Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡